Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case ...
1mon
Snowboarder Brenna Huckaby has 'nothing left to prove' as she chases more Paralympic gold in Cortina
Snowboarder Brenna Huckaby chases a fourth Paralympic gold medal while feeling at peace with her sport and herself. Waiting ...
GRAFTON – Haley was a little nervous during her doctor's appointment. She shivered and cowered, but her mood quickly improved. Haley had a leg amputated nearly a year ago after a diagnosis of an ...
ABSTRACT: We conducted this study to analyze the quality of life using the SF-36 health questionnaire and the MSTS scores depending on surgical method and the primary site of occurrence. On the ...
Osteosarcoma primarily affects long bones in teenagers and young adults, requiring early diagnosis for effective treatment. Treatment strategies vary by stage, with surgery and chemotherapy as primary ...
Please provide your email address to receive an email when new articles are posted on . Inherited mutations in SMARCAL1 are significantly linked to osteosarcoma risk, an analysis of DNA damage repair ...
OS Therapies’ cancer vaccine, OST-HER2, has been shown to significantly improve overall survival (OS) in patients with recurrent, fully resected, pulmonary metastatic osteosarcoma after two years.
Phyllodes tumor (PT) of the breast is a rare fibroepithelial tumor characterized by the proliferation of both epithelial and stromal components. The presence of osteosarcomatous differentiation within ...
Abstract: Osteosarcoma tumors present significant diagnostic challenges due to their complex and heterogeneous structures. This study investigates the integration of advanced signal processing ...
The complex tumor microenvironment (TME) in osteosarcoma is emerging as a critical factor in disease progression and treatment resistance. Recent insights highlight the intricate interplay between ...
Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results